Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Nivolumab Plus Ipilimumab in Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab in Selected Uterine Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)
- Status
- UNKNOWN
- Phase
- PHASE2
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1